Logo
Picture

Alexander A. Morgan, MD PhD @genomicsdoc

25 years working at the intersection of AI, biotech, and healthcare. Partner at Khosla Ventures, investing in the future. linkedin.com/in/genomicsdoc/ San Francisco Joined May 2013
  • Tweets
    5K
  • Followers
    2K
  • Following
    1K
  • Likes
    16K
genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

2 days ago

This is a real step function level improvement in the capability of AI driven drug design. @nablabio is able to fully design a multifunctional/multispecific biologic de novo. This is the way to get to N of 1 personalized biologics.

nablabio Profile Picture

Nabla Bio @nablabio

3 days ago

Today, we expand zero-shot drug design beyond binding to the design of multifunctional medicines, the intracellular proteome, and state-of-the-art atomic precision with our model, JAM-2. In a new report (below), we show: 1. The first drug-grade, fully computationally designed

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

4 days ago

Great piece of visual design.

BiancoDavinci Profile Picture

DaVinci @BiancoDavinci

6 days ago

This Japanese restaurant logo is simultaneously a Japanese crane and a hand holding chopsticks.

Alexander A. Morgan, MD PhD retweeted
TFNBreakingNews Profile Picture

Tech Funding News @TFNBreakingNews

a week ago

📌 Clair Health has closed $11.6 million in seed funding. techfundingnews.com/clair-health-1… The round was led by @khoslaventures, with participation from @speedrun, @brydgeclub, @treehub_in, @cartacapital, @agihouse_org, Insiders VC, and Anne Wojcicki. #womenintech #femalefounders #startups #ustech #technology #innovation #investment #healthtech #news #hormonemonitor

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a week ago

We at @khoslaventures are excited about what @sleepdiplomat is doing, and how AI and data can be used to improve the sleep for everyone.

sleepdiplomat Profile Picture

Matt Walker @sleepdiplomat

4 weeks ago

Building the future of sleep intelligence. Hiring: → Data Scientists → UX Engineers AI, neuroscience, sleep science, data, design. Work directly with Dr. Matt Walker. nightfalliq.com/careers

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a week ago

Another favorite brand: @OchaandCo

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a week ago

"Consistently frequent tea drinkers had a 12% (HR:0.88, 95% CI: 0.77, 0.99) reduced risk of cognitive decline." @ITO_EN

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a week ago

nature.com/articles/s4159…

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a week ago

"subjects with two or three offspring had significantly reduced brain age compared to those without offspring...findings suggest that lifestyle factors accompanying having offspring, rather than the physical process of pregnancy"

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a week ago

frontiersin.org/journals/nutri…

Alexander A. Morgan, MD PhD retweeted
khoslaventures Profile Picture

Khosla Ventures @khoslaventures

4 weeks ago

A landmark day for KV: @vkhosla named #1 on the @Forbes Midas List, 25 years after topping the inaugural edition. First at the birth of the internet. Now at AI’s defining moment. This year, he’s recognized for the first institutional check into @OpenAI – when others saw a not-for-profit research lab with no product and no revenue, Vinod saw the start of the most transformative technology shift in history. Congrats to managing partners @rabois and @SStrohband, recognized for their early bets on @tryramp and @DoorDash, and @RocketLab and @gitlab 🎉 At KV, we back founders bold enough to make the impossible possible. This recognition belongs to the entrepreneurs who see the future before it exists. forbes.com/lists/midas/

Alexander A. Morgan, MD PhD retweeted
bryan_johnson Profile Picture

Bryan Johnson @bryan_johnson

a month ago

These numbers are shocking. It's like we got a new frontier AI model but for the body. Lilly's phase 3 results for retatrutide: > highest dose lost 28.3% of body weight in 80 wks > 70 lbs ave > 45% lost 30% or more of their body weight > 65% on the top dose no longer clinically obese Retatrutide is more dynamic than semaglutide and tirzepatide because it targets three receptors (GIP, GLP-1, and glucagon), versus one and two, respectively. Side effects, on the highest dose (12mg), were higher for retatrutide than tirzepatide (nausea and GI), with an 11.3% drop out rate. The lowest 4mg dose still delivered 19% loss with fewer dropouts than placebo.

Alexander A. Morgan, MD PhD retweeted
bhalligan Profile Picture

Brian Halligan @bhalligan

2 months ago

I don't remember where I found this, but its spot on.

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

a month ago

In case you are looking for a new way of describing the Orchestrator layer, maybe try one of these helpful terms. ageofravensgames.com/blog/the-many-…

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

2 months ago

Congrats to Andy and the whole @Path_AI team! fiercebiotech.com/medtech/roche-…

Alexander A. Morgan, MD PhD retweeted
vkhosla Profile Picture

Vinod Khosla @vkhosla

2 months ago

Robots cracking an egg, slicing tomatoes, cooking an actual omlette, ... pretty unbelievable for 2026! The rate of progress in both hardware and software is awesome.

gs_ai_ Profile Picture

Genesis AI @gs_ai_

2 months ago

We are back. After one year of quiet building. Introducing GENE-26.5, our first robotic brain that takes a major step toward human-level capability. For years, robotics has struggled to learn from the world’s largest and valuable data source: Humans. Solving it means

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

2 months ago

I knew it!

TheBabylonBee Profile Picture

The Babylon Bee @TheBabylonBee

2 months ago

We Asked 100 Women The Most Attractive Quality In A Man And They All Agreed It's Painting Tiny Warhammer Figures buff.ly/yWoWdqr

Alexander A. Morgan, MD PhD retweeted
johncumbers Profile Picture

John Cumbers @johncumbers

2 months ago

Anthropic Says Life Sciences Is Its Biggest Bet After Code. Eric Kauderer-Abrams started @AnthropicAI 's life sciences division ten months ago. He took on the stage at @SynBioBeta with Marc Tessier-Lavigne from @Xaira_Thera , and what caught my attention was how plainly Eric stated the following: "The greatest opportunity to have a beneficial, scaled impact with everything that's happening in frontier AI is in the life sciences." After coding, it's their biggest investment area. They've been training Claude on bioinformatics, chemistry, molecule design, structural biology, clinical regulatory. Their models went from mediocre in life sciences to roughly PhD level across most domains in under a year. That's a steep curve. But what I found more telling than the benchmarks was the infrastructure they're building around it. Wet labs for basic research so their own scientists hit the walls firsthand. An acquisition of Coefficient Bio (acquired by Anthropic) to teach @claudeai how to think like a biotech program manager, not just a bench scientist. The gap between "Claude can answer a biology question" and "Claude can help you run a drug program" is enormous, and they're clearly aware of it. Marc mentioned that 90% of drugs fail in the clinic. Two-thirds of those failures aren't bad science, but patient matching. You have a good target, a good drug, and you can't find who will respond. That's the problem both of them kept circling back to, and it's where causal AI models trained on real perturbation data might actually move the needle. Marc said nobody's pushing a button for a development candidate anytime soon. But Anthropic went from $1B to $30B in revenue in sixteen months. That kind of resource behind this kind of focus is new. It's fun to think of what R&D can look like in the next few months! #SynBioBeta2026 #SyntheticBiology #Biotech #AIxBio

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

2 months ago

The @KariusInc metagenomic blood test (infectious disease liquid biopsy) can identify/diagnose brand new emergent infectious agents (e.g. R. lanei), due to the breadth and power of its sequencing based assay and AI interpretation tools. Hyperscaling #Biosecurity wwwnc.cdc.gov/eid/article/32…

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

2 months ago

The diagnostic performance of @OpenAI continuing to improve. science.org/doi/10.1126/sc…

genomicsdoc Profile Picture

Alexander A. Morgan, MD PhD @genomicsdoc

2 months ago

Awesome shift in clinical study operations by @DrMakaryFDA and @US_FDA. Kudos on pushing this forward.

DrMakaryFDA Profile Picture

Dr. Marty Makary @DrMakaryFDA

2 months ago

A milestone day for clinical trial innovation. We’re announcing the first real-time clinical trials, where @US_FDA can see data signals and endpoints in real time. A quick explainer:

Trends for United States

Dembele
Norway
Senegal
Haaland
Scott
Bolton
Haitians
Pape Gueye
Dan Patrick
#AlgarveWordAblaze
#DoorDashFairy
#NORFRA
Strand Larsen
Noruega
Phil
Chasten
John Thune
Demi Moore
RIP Fridge
Doue

You might like

Climatetech @ Frontier via BioE PhD, @a16z investor, founder. Tweets on 🏔️ climate, 🧬 syn bio, 💊 therapeutics, 👩‍💻 comp bio, 🌱 agriculture, 🚀 startups
Judy Savitskaya
@heyjudka
9K Followers
Founder & CEO @envedabio I Son, husband, and teammate I India ‣ US for PhD @UWMadison I Love solving hard problems with amazing people
Viswa Colluru
@viswacolluru
1K Followers
Harvard-MIT Health Sciences and Technology. Integrating science, engineering, and medicine to solve problems in human health.
HST
@mit_hst
7K Followers
investing in atoms @cantos | community building @decodingbio | @stanfordgsb @JHUbme
Amee Kapadia
@ameekapadia
5K Followers
physician-scientist turned biotech investor @KdT_Ventures | helping founders build science and tech-driven companies | writing at https://t.co/w5M8DV8u92
Patrick Malone, MD Ph...
@patricksmalone
8K Followers
biotech startups @pillar_vc, ai for science @encode_pillarvc founding team @EdisonSci Prior: @petribio @MIT, @BroadInstitute
Tony Kulesa
@kulesatony
10K Followers
CEO of @radialscience at @AsteraInstitute. Previously Investor @a16zbiohealth, BD / R&D @Amgen, R&D @Genentech. Proud alum of @Cal & @MIT. Girl mom. Coastsider.
Becky Pferdehirt
@beckypferdehirt
3K Followers
building @ enveda | https://t.co/JaCPdwmcki
Pablo Lubroth
@pablolubroth
2K Followers
Co-Founder and CEO @LatchBio — Intelligence Infra for Biology
Alfredo Andere
@AlfredoAndere
5K Followers
Company founder and venture capitalist focused on disruptive innovation, esp. biotechnology and AI. Active angel in tech. Fierce Optimist.
Robert Nelsen
@rtnarch
26K Followers
searching for near-life technologies. partner @compoundVC | writing https://t.co/5sTPXkv3ML
Dr. Shelby
@shelbynewsad
6K Followers
1st check for deep tech @Astra (NASDAQ: ASTR) @Planet (NYSE: PL) @MammothBioSci @GalileoHealth @SwarmInternet (@SpaceX) @faunabio @gotoimpulse Ex: @iendeavors
Cee Cee Schnugg
@ceeceeboom
2K Followers
building the autonomous factory for your own stem cells @cellinobio · physicist → biology · making reprogramming manufacturable
Dr. Nabiha Saklayen
@nabihasaklayen
3K Followers
CEO @Conception (generating human eggs to help treat infertility) Started @SciFounders (helping scientists start companies)
Matt Krisiloff
@mattkrisiloff
8K Followers
Batman; Investor X Computer Scientist. Founder @_DimensionCap
Zavain Dar
@zavaindar
13K Followers